CN1263436A - 在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸 - Google Patents

在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸 Download PDF

Info

Publication number
CN1263436A
CN1263436A CN98805612A CN98805612A CN1263436A CN 1263436 A CN1263436 A CN 1263436A CN 98805612 A CN98805612 A CN 98805612A CN 98805612 A CN98805612 A CN 98805612A CN 1263436 A CN1263436 A CN 1263436A
Authority
CN
China
Prior art keywords
seq
ghpo
gly
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98805612A
Other languages
English (en)
Chinese (zh)
Inventor
H·克利恩索斯
A·阿尔加拉威
C·米勒
J·－F·图姆
R·P·奥门
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERIEUX ORAVAX
Human Genome Sciences Inc
Original Assignee
MERIEUX ORAVAX
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MERIEUX ORAVAX, Human Genome Sciences Inc filed Critical MERIEUX ORAVAX
Publication of CN1263436A publication Critical patent/CN1263436A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN98805612A 1997-04-01 1998-04-01 在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸 Pending CN1263436A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US83345797A 1997-04-01 1997-04-01
US08/833,457 1997-04-01
US88122797A 1997-06-24 1997-06-24
US08/881,227 1997-06-24
US90261597A 1997-07-29 1997-07-29
US08/902,615 1997-07-29

Publications (1)

Publication Number Publication Date
CN1263436A true CN1263436A (zh) 2000-08-16

Family

ID=27420239

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98805612A Pending CN1263436A (zh) 1997-04-01 1998-04-01 在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸

Country Status (8)

Country Link
EP (1) EP0977482A4 (fr)
JP (1) JP2001527393A (fr)
KR (1) KR20010005893A (fr)
CN (1) CN1263436A (fr)
AU (1) AU756010B2 (fr)
CA (1) CA2286306A1 (fr)
NZ (1) NZ338039A (fr)
WO (1) WO1998043478A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108495650A (zh) * 2015-12-14 2018-09-04 慕尼黑工业大学 幽门螺杆菌疫苗
CN112194706A (zh) * 2020-09-30 2021-01-08 广州派真生物技术有限公司 腺相关病毒突变体及其应用
CN118063569A (zh) * 2024-04-24 2024-05-24 上海金翌生物科技有限公司 一种幽门螺杆菌分泌蛋白及其在检测幽门螺杆菌中的应用

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19847628C2 (de) * 1998-10-15 2000-10-19 Chiron Behring Gmbh & Co Helicobacter pylori-Impfstoff
US6238894B1 (en) 1998-11-04 2001-05-29 Diane Taylor α1,2 fucosyltransferase
AU5399800A (en) * 1999-05-31 2000-12-18 Creatogen Aktiengesellschaft Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
WO2001008486A1 (fr) * 1999-08-03 2001-02-08 Smithkline Beecham Corporation POLYPEPTIDES ET POYLNUCLEOTIDES CoaA ET PROCEDES ASSOCIES
AUPQ347199A0 (en) 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US20030180330A1 (en) * 2000-04-27 2003-09-25 Meyer Thomas F Method for identifying helicobacter antigens
SE0001988D0 (sv) * 2000-05-29 2000-05-29 A & Science Invest Ab Novel polypeptides and use thereof
WO2002000888A1 (fr) * 2000-06-28 2002-01-03 National Research Council Of Canada Polypeptides de l'heptosyltransferase d'helicobacter pylori
US20040033240A1 (en) * 2000-07-05 2004-02-19 Bruno Guy Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
ATE468391T1 (de) * 2001-08-24 2010-06-15 Kyowa Hakko Bio Co Ltd Alpha-1,2-fucosyl-transferase und diese codierende dna
KR20030024129A (ko) * 2001-09-17 2003-03-26 국윤호 헬리코박터 파일로리의 탐지 및 동정 방법
AU2003218551A1 (en) * 2002-03-26 2003-10-08 National Research Council Of Canada Helicobacter flagellar, motility polypeptides
JP3823268B2 (ja) * 2002-05-30 2006-09-20 独立行政法人科学技術振興機構 ヘリコバクター・ピロリの細胞死誘導剤
WO2005023851A1 (fr) * 2003-09-05 2005-03-17 Karolinska Innovations Ab Polypeptides de liaison au plasminogene/a la plasmine et acides nucleiques associes
KR20060129229A (ko) * 2003-11-21 2006-12-15 에이스 바이오사이언시즈 에이/에스 표면에 위치한 빈창자캄필로박터 폴리펩티드
KR101985335B1 (ko) * 2017-11-01 2019-06-03 연세대학교 원주산학협력단 피시알-리버스 블랏 교잡 어세이 기반 헬리코박터 파이로리균 및 그 균의 항생제 내성에 관련된 유전자의 검출을 확인할 수 있는 진단법 및 그 응용
PE20251773A1 (es) * 2022-11-29 2025-07-14 Jeil Pharmaceutical Co Ltd Composicion para eliminar helicobacter pylori que comprende zastaprazan o una sal farmaceuticamente aceptable del mismo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8928625D0 (en) * 1989-12-19 1990-02-21 3I Res Expl Ltd H.pylori dna probes

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108495650A (zh) * 2015-12-14 2018-09-04 慕尼黑工业大学 幽门螺杆菌疫苗
CN112194706A (zh) * 2020-09-30 2021-01-08 广州派真生物技术有限公司 腺相关病毒突变体及其应用
CN112194706B (zh) * 2020-09-30 2022-03-08 广州派真生物技术有限公司 腺相关病毒突变体及其应用
CN118063569A (zh) * 2024-04-24 2024-05-24 上海金翌生物科技有限公司 一种幽门螺杆菌分泌蛋白及其在检测幽门螺杆菌中的应用
CN118063569B (zh) * 2024-04-24 2024-08-30 上海金翌生物科技有限公司 一种幽门螺杆菌分泌蛋白及其在检测幽门螺杆菌中的应用

Also Published As

Publication number Publication date
EP0977482A4 (fr) 2002-03-06
CA2286306A1 (fr) 1998-10-08
AU7099598A (en) 1998-10-22
NZ338039A (en) 2001-04-27
AU756010B2 (en) 2003-01-02
EP0977482A1 (fr) 2000-02-09
WO1998043478A1 (fr) 1998-10-08
JP2001527393A (ja) 2001-12-25
KR20010005893A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
CN1263436A (zh) 在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸
CN1437653A (zh) 抗原多肽
CN1279717A (zh) 肺炎衣原体的基因组序列和其多肽、片段以及其用途特别是用于诊断、预防和治疗感染
CN1280619A (zh) 沙眼衣原体的基因组序列和多肽,其片段以及其用途,特别是用于诊断、预防和治疗感染
CN1636062A (zh) 编码多肽抗原的新肺炎链球菌可读框及其应用
CN1284965A (zh) 脑膜炎奈瑟氏球菌的新表面蛋白
CN1251611A (zh) 粘膜炎莫拉菌的uspa1和uspa2抗原
IL259316B2 (en) A novel surface exposed haemophilus influenzae protein (protein e; pe)
CN1235555A (zh) 治疗和诊断分枝杆菌感染的化合物和方法
CN1440419A (zh) 治疗和预防细菌感染的化合物和方法
CN1351653A (zh) 抗细菌疫苗组合物
CN1294632A (zh) 得自母牛分枝杆菌的组合物及其使用方法
CN1220703A (zh) 与幽门螺杆菌及其疫备组合物有关的核酸和氨基酸序列
CN1235513A (zh) 与幽门螺杆菌及其疫苗组合物有关的核酸和氨基酸序列
CN1427892A (zh) 毒力基因、蛋白及其用途
CN1246799A (zh) 关于幽门螺杆菌的核酸序列和氨基酸序列及其疫苗组合物
CN1261403A (zh) 新的肺炎衣原体表面蛋白
CN1275164A (zh) 奈瑟氏球菌乳铁蛋白结合蛋白
CN1198931C (zh) 粘膜炎莫拉氏菌basb034多肽及应用
CN1331699A (zh) 鉴定抗原基因序列的方法
CN1210401C (zh) 源自粘膜炎莫拉氏菌的化合物
CN1375006A (zh) 新型化合物
CN1371389A (zh) 疫苗
CN1377369A (zh) 莫拉氏菌属的疫苗抗原
CN1186516A (zh) 与幽门螺杆菌相关的诊断和治疗用的核酸和氨基酸序列

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication